Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer
Alphamab Oncology a clinical stage biopharmaceutical company focusing on innovative biologics medicine for oncology, and Sanofi, a global biopharmaceutical leader, announced today that…
Read More...
Read More...
